Autoantibodies to protein-arginine deiminase (PAD) 4 in rheumatoid arthritis: immunological and clinical significance, and potential for precision medicine

References

• Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev. 2012 Aug;11(10):754–765. PubMed PMID: 22387972; eng.
   PubMed Web of Science ®Google Scholar
• Deane KD, Demoruelle MK, Kelmenson LB, et al. Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2017;31(1):3–18. PubMed PMID: 29221595.
   PubMed Web of Science ®Google Scholar
• Martinez-Prat L, Nissen MJ, Lamacchia C, et al. comparison of serological biomarkers in rheumatoid arthritis and their combination to improve diagnostic performance. Front Immunol. 2018;9:1113. PubMed PMID: 29928272; PubMed Central PMCID: PMCPMC5997814. eng.
   PubMed Web of Science ®Google Scholar
• Trouw LA, Mahler M. Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis. Autoimmun Rev. 2012 Dec;12(2):318–322. PubMed PMID: 22664776; eng.
   PubMed Web of Science ®Google Scholar
• Shi J, Knevel R, Suwannalai P, et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17372–17377. PubMed PMID: 21987802; PubMed Central PMCID: PMCPMC3198314. eng.
   PubMed Web of Science ®Google Scholar
• Truchetet ME, Dublanc S, Barnetche T, et al. ASSOCIATION of the presence of anti-carbamylated protein antibodies in early arthritis with a poorer clinical and radiologic outcome: data from the French ESPOIR cohort. Arthritis Rheumatol (Hoboken). 2017 Dec;69(12):2292–2302. PubMed PMID: 28853240; eng.
   PubMed Web of Science ®Google Scholar
• Shi J, Milo J, Brady K, et al. Diagnostic performance of a new anti-carbamylated protein assay in rheumatic diseases. Scand J Rheumatol. 2018 Nov 13:1–2. PubMed PMID: 30422725; eng. DOI:10.1080/03009742.2018.1530372.
   Web of Science ®Google Scholar
• Yee A, Webb T, Seaman A, et al. Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. Immunol Res. 2015 Feb;61(1–2):24–30. PubMed PMID: 25391608; eng.
   PubMed Web of Science ®Google Scholar
• Auger I, Martin M, Balandraud N, et al. Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen. Arthritis Rheum. 2010 Jan;62(1):126–131. PubMed PMID: 20039406.
   PubMedGoogle Scholar
• Auger I, Charpin C, Balandraud N, et al. Autoantibodies to PAD4 and BRAF in rheumatoid arthritis. Autoimmun Rev. 2012 Sep;11(11):801–803. PubMed PMID: 22349616; eng.
   PubMed Web of Science ®Google Scholar
• Darrah E, Giles JT, Ols ML, et al. Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity. Sci Transl Med. 2013 May 22;5(186):186ra65. PubMed PMID: 23698378; PubMed Central PMCID: PMCPMC3740946.
   PubMed Web of Science ®Google Scholar
• Darrah E, Giles JT, Davis RL, et al. Autoantibodies to peptidylarginine deiminase 2 are associated with less severe disease in rheumatoid arthritis. Front Immunol. 2018;9:2696. PubMed PMID: 30515171.
   PubMed Web of Science ®Google Scholar
• Nissinen R, Paimela L, Julkunen H, et al. Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjogren syndrome. Scand J Rheumatol. 2003;32(6):337–342. PubMed PMID: 15080264; eng.
   PubMed Web of Science ®Google Scholar
• Witalison EE, Thompson PR, Hofseth LJ. Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation. Curr Drug Targets. 2015;16(7):700–710. PubMed PMID: 25642720.
   PubMed Web of Science ®Google Scholar
• Lewis HD, Nacht M. iPAD or PADi—‘tablets’ with therapeutic disease potential? Curr Opin Chem Biol. 2016;33:169–178.
   PubMed Web of Science ®Google Scholar
• Willis VC, Banda NK, Cordova KN, et al. Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis. Clin Exp Immunol. 2017 May;188(2):263–274. PubMed PMID: 28128853; PubMed Central PMCID: PMCPMC5383440. eng.
   PubMed Web of Science ®Google Scholar
• Gyorgy B, Toth E, Tarcsa E, et al. Citrullination: a posttranslational modification in health and disease. Int J Biochem Cell Biol. 2006;38(10):1662–1677. PubMed PMID: 16730216; eng.
   PubMed Web of Science ®Google Scholar
• Christophorou MA, Castelo-Branco G, Halley-Stott RP, et al. Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature. 2014 Mar 6;507(7490):104–108. PubMed PMID: 24463520; PubMed Central PMCID: PMCPMC4843970. eng.
   PubMed Web of Science ®Google Scholar
• Slade DJ, Subramanian V, Thompson PR. Pluripotency: citrullination unravels stem cells. Nat Chem Biol. 2014 May;10(5):327–328. PubMed PMID: 24743255; PubMed Central PMCID: PMCPMC4632640. eng.
   PubMed Web of Science ®Google Scholar
• Yuzhalin AE. Citrullination in Cancer. Cancer Res. 2019;79(7):1274–1284.
   PubMed Web of Science ®Google Scholar
• Ishigami A, Ohsawa T, Hiratsuka M, et al. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer’s disease. J Neurosci Res. 2005 Apr 1;80(1):120–128. PubMed PMID: 15704193; eng.
   PubMed Web of Science ®Google Scholar
• Anzilotti C, Pratesi F, Tommasi C, et al. Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmun Rev. 2010 Jan;9(3):158–160. PubMed PMID: 19540364; eng.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy A, Joshua V, Haj Hensvold A, et al. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann Rheum Dis. 2016 Apr;75(4):721–729. PubMed PMID: 26612338; PubMed Central PMCID: PMCPMC4819614. eng.
   PubMed Web of Science ®Google Scholar
• Valesini G, Gerardi MC, Iannuccelli C, et al. Citrullination and autoimmunity. Autoimmun Rev. 2015 Jun;14(6):490–497. PubMed PMID: 25636595; eng.
   PubMed Web of Science ®Google Scholar
• Wang F, Chen FF, Gao WB, et al. Identification of citrullinated peptides in the synovial fluid of patients with rheumatoid arthritis using LC-MALDI-TOF/TOF. Clin Rheumatol. 2016 Sep;35(9):2185–2194. PubMed PMID: 27060082; PubMed Central PMCID: PMCPMC4989008. eng.
   PubMed Web of Science ®Google Scholar
• Darrah E, Rosen A, Giles JT, et al. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis. Ann Rheum Dis. 2012 Jan;71(1):92–98. PubMed PMID: 21859690; PubMed Central PMCID: PMCPMC3302156.
   PubMed Web of Science ®Google Scholar
• Vossenaar ER, Zendman AJ, van Venrooij WJ, et al. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays. 2003 Nov;25(11):1106–1118. PubMed PMID: 14579251.
   PubMed Web of Science ®Google Scholar
• Papayannopoulos V. Neutrophil extracellular traps in immunity and disease [Review Article]. Nat Rev Immunol. 2017;18:134.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li M, Stadler S, et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol. 2009 Jan 26;184(2):205–213. PubMed PMID: 19153223; PubMed Central PMCID: PMCPMC2654299. eng.
   PubMed Web of Science ®Google Scholar
• Bawadekar M, Shim D, Johnson CJ, et al. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation. J Autoimmun. 2017 Jun;80:39–47. PubMed PMID: 28188029; PubMed Central PMCID: PMCPMC5422119. eng.
   PubMed Web of Science ®Google Scholar
• Corsiero E, Pratesi F, Prediletto E, et al. NETosis as Source of Autoantigens in Rheumatoid Arthritis [Review]. Front Immunol. 2016;7(485). English. DOI:10.3389/fimmu.2016.00485.
   Google Scholar
• Okroj M, Heinegard D, Holmdahl R, et al. Rheumatoid arthritis and the complement system. Ann Med. 2007;39(7):517–530. PubMed PMID: 17852027; eng.
   PubMed Web of Science ®Google Scholar
• Ge C, Holmdahl R. The structure, specificity and function of anti-citrullinated protein antibodies. Nat Rev Rheumatol. 2019 Aug;15(8):503–508. PubMed PMID: 31253945; eng.
   PubMed Web of Science ®Google Scholar
• Sun B, Dwivedi N, Bechtel TJ, et al. Citrullination of NF-kappaB p65 promotes its nuclear localization and TLR-induced expression of IL-1beta and TNFalpha. Sci Immunol. 2017 Jun 9;2(12). PubMed PMID: 28783661; PubMed Central PMCID: PMCPMC5718838. eng. DOI:10.1126/sciimmunol.aal3062.
   Web of Science ®Google Scholar
• Ishigami A, Ohsawa T, Asaga H, et al. Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin. Arch Biochem Biophys. 2002 Nov 1;407(1):25–31. PubMed PMID: 12392711; eng.
   PubMed Web of Science ®Google Scholar
• Assohou-Luty C, Raijmakers R, Benckhuijsen WE, et al. The human peptidylarginine deiminases type 2 and type 4 have distinct substrate specificities. Biochim Biophys Acta. 2014 Apr;1844(4):829–836. PubMed PMID: 24594197; eng.
   PubMed Web of Science ®Google Scholar
• Rogers GE, Harding HW, Llewellyn-Smith IJ. The origin of citrulline-containing proteins in the hair follicle and the chemical nature of trichohyalin, an intracellular precursor. Biochim Biophys Acta. 1977 Nov 25;495(1):159–175. PubMed PMID: 410454; eng.
   PubMedGoogle Scholar
• Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997 Sep 1;25(17):3389–3402. PubMed PMID: 9254694; PubMed Central PMCID: PMCPMC146917. eng.
   PubMed Web of Science ®Google Scholar
• Guerrin M, Ishigami A, Mechin MC, et al. cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I. Biochem J. 2003 Feb 15;370(Pt 1):167–174. PubMed PMID: 12416996; PubMed Central PMCID: PMCPMC1223146. eng.
   PubMedGoogle Scholar
• Saijo S, Nagai A, Kinjo S, et al. Monomeric form of peptidylarginine deiminase type I Revealed by X-ray crystallography and small-angle X-ray scattering. J Mol Biol. 2016;428(15):3058–3073.
   PubMed Web of Science ®Google Scholar
• Nachat R, Mechin MC, Charveron M, et al. Peptidylarginine deiminase isoforms are differentially expressed in the anagen hair follicles and other human skin appendages. J Invest Dermatol. 2005 Jul;125(1):34–41. PubMed PMID: 15982300; eng.
   PubMed Web of Science ®Google Scholar
• Moscarello MA, Mastronardi FG, Wood DD. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res. 2007;32(2):251–256. PubMed PMID: 17031564; eng.
   PubMed Web of Science ®Google Scholar
• Wood DD, Bilbao JM, O’Connors P, et al. Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol. 1996 Jul;40(1):18–24. PubMed PMID: 8687186; eng.
   PubMed Web of Science ®Google Scholar
• Slade DJ, Fang P, Dreyton CJ, et al. Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design. ACS Chem Biol. 2015 Apr 17;10(4):1043–1053. PubMed PMID: 25621824; PubMed Central PMCID: PMCPMC4569063.
   PubMed Web of Science ®Google Scholar
• Burkhardt H, Sehnert B, Bockermann R, et al. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol. 2005 May;35(5):1643–1652. PubMed PMID: 15832289; eng.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Joo M, Abdolrasulnia R, et al. Peptidylarginine deiminase 2 suppresses inhibitory {kappa}B kinase activity in lipopolysaccharide-stimulated RAW 264.7 macrophages. J Biol Chem. 2010 Dec 17;285(51):39655–39662. PubMed PMID: 20937835; PubMed Central PMCID: PMCPMC3000946. eng.
   PubMed Web of Science ®Google Scholar
• Zhang X, Bolt M, Guertin MJ, et al. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor alpha target gene activation. Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13331–13336. PubMed PMID: 22853951; PubMed Central PMCID: PMCPMC3421185. eng.
   PubMed Web of Science ®Google Scholar
• Horibata S, Coonrod SA, Cherrington BD. Role for peptidylarginine deiminase enzymes in disease and female reproduction. J Reprod Dev. 2012;58(3):274–282. PubMed PMID: 22790870; eng.
   PubMed Web of Science ®Google Scholar
• Rogers GE, Simmonds DH. Content of citrulline and other amino-acids in a protein of hair follicles. Nature. 1958 Jul 19;182(4629):186–187. PubMed PMID: 13566234; eng.
   PubMed Web of Science ®Google Scholar
• UB FB, Cau L, Tafazzoli A, et al. Mutations in three genes encoding proteins involved in hair shaft formation cause uncombable hair syndrome. Am J Hum Genet. 2016 Dec 1;99(6):1292–1304. PubMed PMID: 27866708; PubMed Central PMCID: PMCPMC5142115. eng.
   PubMed Web of Science ®Google Scholar
• Cuthbert GL, Daujat S, Snowden AW, et al. Histone deimination antagonizes arginine methylation. Cell. 2004 Sep 3;118(5):545–553. PubMed PMID: 15339660; eng.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wysocka J, Sayegh J, et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science (New York, NY). 2004 Oct 8;306(5694):279–283. PubMed PMID: 15345777; eng.
   Google Scholar
• Chang X, Han J, Pang L, et al. Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer. 2009 Jan;30(9):40. PubMed PMID: 19183436; PubMed Central PMCID: PMCPMC2637889. eng.
   PubMed Web of Science ®Google Scholar
• Nakashima K, Hagiwara T, Yamada M. Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. J Biol Chem. 2002 Dec 20;277(51):49562–49568. PubMed PMID: 12393868; eng.
   PubMed Web of Science ®Google Scholar
• Neeli I, Khan SN, Radic M. Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol. 2008;180(3):1895–1902. PubMed PMID: 18209087; eng.
   PubMed Web of Science ®Google Scholar
• Lee YH, Coonrod SA, Kraus WL, et al. Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination. Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3611–3616. PubMed PMID: 15731352; PubMed Central PMCID: PMCPMC553305. eng.7.
   PubMed Web of Science ®Google Scholar
• Asaga H, Nakashima K, Senshu T, et al. Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils. J Leukoc Biol. 2001 Jul;70(1):46–51. PubMed PMID: 11435484; eng.
   PubMed Web of Science ®Google Scholar
• Hagiwara T, Nakashima K, Hirano H, et al. Deimination of arginine residues in nucleophosmin/b23 and histones in hl-60 granulocytes. Biochem Biophys Res Commun. 2002;290(3):979–983.
   PubMed Web of Science ®Google Scholar
• Guo Q, Fast W. Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53. J Biol Chem. 2011 May 13;286(19):17069–17078. PubMed PMID: 21454715; PubMed Central PMCID: PMCPMC3089551. eng.
   PubMed Web of Science ®Google Scholar
• Xu Y, Shi Y, Fu J, et al. Mutations in PADI6 cause female infertility characterized by early embryonic arrest. Am J Hum Genet. 2016 Sep 1;99(3):744–752. PubMed PMID: 27545678; PubMed Central PMCID: PMCPMC5010645. eng.
   PubMed Web of Science ®Google Scholar
• Rose R, Rose M, Ottmann C. Identification and structural characterization of two 14-3-3 binding sites in the human peptidylarginine deiminase type VI. J Struct Biol. 2012 Oct;180(1):65–72. PubMed PMID: 22634725; eng.
   PubMed Web of Science ®Google Scholar
• Zhang J, Dai J, Zhao E, et al. cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type VI. Acta Biochim Pol. 2004;51(4):1051–1058. PubMed PMID: 15625577; eng.
   PubMed Web of Science ®Google Scholar
• Chavanas S, Mechin MC, Takahara H, et al. Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6. Gene. 2004 Apr;14(330):19–27. PubMed PMID: 15087120; eng.
   PubMed Web of Science ®Google Scholar
• Wood DD, Ackerley CA, Brand B, et al. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities. Lab Invest. 2008 Apr;88(4):354–364. PubMed PMID: 18227806; eng.
   PubMed Web of Science ®Google Scholar
• Mohanan S, Cherrington BD, Horibata S, et al. Potential role of peptidylarginine deiminase enzymes and protein citrullination in cancer pathogenesis. Biochem Res Int. 2012;2012:895343. PubMed PMID: 23019525; eng.
   PubMedGoogle Scholar
• Cherrington BD, Zhang X, McElwee JL, et al. Potential role for pad2 in gene regulation in breast cancer cells. Plos One. 2012;7(7):e41242.
   PubMed Web of Science ®Google Scholar
• Tarcsa E, Marekov LN, Mei G, et al. Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem. 1996 Nov 29;271(48):30709–30716. PubMed PMID: 8940048; eng.
   PubMed Web of Science ®Google Scholar
• Foulquier C, Sebbag M, Clavel C, et al. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum. 2007 Nov;56(11):3541–3553. PubMed PMID: 17968929; eng.
   PubMed Web of Science ®Google Scholar
• Ikari K, Kuwahara M, Nakamura T, et al. Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheumatism. 2005 Oct;52(10):3054–3057. PubMed PMID: 16200584; eng.
   PubMedGoogle Scholar
• Iwamoto T, Ikari K, Nakamura T, et al. Association between PADI4 and rheumatoid arthritis: a meta-analysis. Rheumatology (Oxford). 2006 Jul;45(7):804–807. PubMed PMID: 16449362; eng.
   PubMed Web of Science ®Google Scholar
• Plenge RM, Padyukov L, Remmers EF, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet. 2005 Dec;77(6):1044–1060. PubMed PMID: 16380915; PubMed Central PMCID: PMCPMC1285162. eng.
   PubMed Web of Science ®Google Scholar
• Panati K, Pal S, Rao KV, et al. Association of single nucleotide polymorphisms (SNPs) of PADI4 gene with rheumatoid arthritis (RA) in Indian population. Genes Genet Syst. 2012;87(3):191–196. PubMed PMID: 22976394; eng.
   PubMed Web of Science ®Google Scholar
• Too CL, Murad S, Dhaliwal JS, et al. Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis. Arthritis Res Ther. 2012;14(6):R250–R250. PubMed PMID: 23164236.
   PubMed Web of Science ®Google Scholar
• Hoppe B, Heymann GA, Tolou F, et al. High variability of peptidylarginine deiminase 4 (PADI4) in a healthy white population: characterization of six new variants of PADI4 exons 2-4 by a novel haplotype-specific sequencing-based approach. J Mol Med (Berl). 2004 Nov;82(11):762–767. PubMed PMID: 15338034; eng.
   PubMed Web of Science ®Google Scholar
• Martinez A, Valdivia A, Pascual-Salcedo D, et al. PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population. Rheumatology (Oxford). 2005 Oct;44(10):1263–1266. PubMed PMID: 15998632; eng.
   PubMed Web of Science ®Google Scholar
• Burr ML, Naseem H, Hinks A, et al. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann Rheum Dis. 2010 Apr;69(4):666–670. PubMed PMID: 19470526; PubMed Central PMCID: PMCPMC2927647. eng.
   PubMed Web of Science ®Google Scholar
• Andrade F, Darrah E, Gucek M, et al. Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. Arthritis Rheumatism. 2010 Jun;62(6):1630–1640. PubMed PMID: 20201080; PubMed Central PMCID: PMCPMC2951335. eng.
   PubMedGoogle Scholar
• Takizawa Y, Suzuki A, Sawada T, et al. Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids. Ann Rheum Dis. 2006 Aug;65(8):1013–1020. PubMed PMID: 16449316; PubMed Central PMCID: PMCPMC1798256. eng.
   PubMed Web of Science ®Google Scholar
• Tutturen AE, Fleckenstein B, de Souza GA. Assessing the citrullinome in rheumatoid arthritis synovial fluid with and without enrichment of citrullinated peptides. J Proteome Res. 2014 Jun 6;13(6):2867–2873. PubMed PMID: 24724574; eng.
   PubMed Web of Science ®Google Scholar
• Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol. 2001 Mar 15;166(6):4177–4184. PubMed PMID: 11238669; eng.
   PubMed Web of Science ®Google Scholar
• Damgaard D, Bawadekar M, Senolt L, et al. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3. PLoS One. 2018;13(8):e0203214. PubMed PMID: 30161253; PubMed Central PMCID: PMCPMC6117052. eng.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang Y. Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. Biochim Biophys Acta. 2013 Oct;1829(10):1126–1135. PubMed PMID: 23860259; PubMed Central PMCID: PMCPMC3775966. eng.
   PubMed Web of Science ®Google Scholar
• Nakayama-Hamada M, Suzuki A, Kubota K, et al. Comparison of enzymatic properties between hPADI2 and hPADI4. Biochem Biophys Res Commun. 2005 Feb 4;327(1):192–200. PubMed PMID: 15629448; eng.
   PubMed Web of Science ®Google Scholar
• Blachère NE, Parveen S, Frank MO, et al. High-titer rheumatoid arthritis antibodies preferentially bind fibrinogen citrullinated by peptidylarginine deiminase 4. Arthritis Rheumatol. 2017;69(5):986–995.
   PubMed Web of Science ®Google Scholar
• Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977 Sep 1;146(3):857–868. PubMed PMID: 894190; PubMed Central PMCID: PMCPMC2180804.
   PubMed Web of Science ®Google Scholar
• Holmdahl R, Jansson L, Larsson E, et al. Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum. 1986 Jan;29(1):106–113. PubMed PMID: 3947407.
   PubMedGoogle Scholar
• Kuhn KA, Kulik L, Tomooka B, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest. 2006 Apr;116(4):961–973. PubMed PMID: 16585962; PubMed Central PMCID: PMCPMC1421345.
   PubMed Web of Science ®Google Scholar
• Ho PP, Higgins JP, Kidd BA, et al. Tolerizing DNA vaccines for autoimmune arthritis. Autoimmunity. 2006 Dec;39(8):675–682. PubMed PMID: 17178564.
   PubMed Web of Science ®Google Scholar
• Ho PP, Lee LY, Zhao X, et al. Autoimmunity against fibrinogen mediates inflammatory arthritis in mice. J Immunol. 2010 Jan 1;184(1):379–390. PubMed PMID: 19949094; PubMed Central PMCID: PMCPMC3412066.
   PubMed Web of Science ®Google Scholar
• Kidd BA, Ho PP, Sharpe O, et al. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res Ther. 2008;10(5):R119. PubMed PMID: 18826638; PubMed Central PMCID: PMCPMC2592807.
   PubMed Web of Science ®Google Scholar
• Zhao X, Okeke NL, Sharpe O, et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther. 2008;10(4):R94. PubMed PMID: 18710572; PubMed Central PMCID: PMCPMC2575608.
   PubMed Web of Science ®Google Scholar
• Sohn DH, Rhodes C, Onuma K, et al. Local Joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis. Arthritis Rheumatol. 2015 Nov;67(11):2877–2887. PubMed PMID: 26227989; PubMed Central PMCID: PMCPMC4626401.
   PubMed Web of Science ®Google Scholar
• Hill JA, Al-Bishri J, Gladman DD, et al. Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis. J Rheumatol. 2006 Nov;33(11):2115–2119. PubMed PMID: 16924693.
   PubMed Web of Science ®Google Scholar
• Hill JA, Bell DA, Brintnell W, et al. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med. 2008 Apr 14;205(4):967–979. PubMed PMID: 18391064; PubMed Central PMCID: PMCPMC2292232.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Kochi Y, Shoda H, et al. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice. BMC Musculoskelet Disord. 2016 May;5(17):205. PubMed PMID: 27150598; PubMed Central PMCID: PMCPMC4858923. eng.
   PubMed Web of Science ®Google Scholar
• Rohrbach AS, Hemmers S, Arandjelovic S, et al. PAD4 is not essential for disease in the K/BxN murine autoantibody-mediated model of arthritis. Arthritis Res Ther. 2012 May 2;14(3):R104. PubMed PMID: 22551352; PubMed Central PMCID: PMCPMC3446481.
   PubMed Web of Science ®Google Scholar
• Seri Y, Shoda H, Suzuki A, et al. Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model. Sci Rep. 2015 Aug;21(5):13041. PubMed PMID: 26293116; PubMed Central PMCID: PMCPMC4544002.
   PubMed Web of Science ®Google Scholar
• Willis VC, Gizinski AM, Banda NK, et al. N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J Immunol. 2011 Apr 1;186(7):4396–4404. PubMed PMID: 21346230; PubMed Central PMCID: PMCPMC3085980. eng.
   PubMed Web of Science ®Google Scholar
• Kawaguchi H, Matsumoto I, Osada A, et al. Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interleukin-6. Mod Rheumatol. 2018;1–6. DOI:10.1080/14397595.2018.1532545.
   PubMed Web of Science ®Google Scholar
• Knight JS, Subramanian V, O’Dell AA, et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Ann Rheum Dis. 2015 Dec;74(12):2199–2206. PubMed PMID: 25104775; PubMed Central PMCID: PMCPMC4320672.
   PubMed Web of Science ®Google Scholar
• Kawalkowska J, Quirke AM, Ghari F, et al. Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses. Sci Rep. 2016 May;23(6):26430. PubMed PMID: 27210478; PubMed Central PMCID: PMCPMC4876390.
   PubMed Web of Science ®Google Scholar
• Halvorsen EH, Pollmann S, Gilboe IM, et al. Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity. Ann Rheum Dis. 2008 Mar;67(3):414–417. PubMed PMID: 18006540.
   PubMed Web of Science ®Google Scholar
• Takizawa Y, Sawada T, Suzuki A, et al. Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis. Scand J Rheumatol. 2005;34(3):212–215. PubMed PMID: 16134727; eng.
   PubMed Web of Science ®Google Scholar
• Roth EB, Stenberg P, Book C, et al. Antibodies against transglutaminases, peptidylarginine deiminase and citrulline in rheumatoid arthritis–new pathways to epitope spreading. Clin Exp Rheumatol. 2006;24(1):12–18. PubMed PMID: 16539813; eng.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhao Y, He J, et al. Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis. J Rheumatol. 2008;35(6):969–974. PubMed PMID: 18398945; eng.
   PubMed Web of Science ®Google Scholar
• Harris ML, Darrah E, Lam GK, et al. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheumatism. 2008 Jul;58(7):1958–1967. PubMed PMID: 18576335; PubMed Central PMCID: PMCPMC2692635. eng.
   PubMedGoogle Scholar
• Halvorsen EH, Haavardsholm EA, Pollmann S, et al. Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents. Ann Rheum Dis. 2009 Feb;68(2):249–252. PubMed PMID: 18723564; eng.
   PubMed Web of Science ®Google Scholar
• Auger I, Balandraud N, Rak J, et al. New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA. Ann Rheum Dis. 2009 Apr;68(4):591–594. PubMed PMID: 18957483; eng.
   PubMed Web of Science ®Google Scholar
• Kolfenbach JR, Deane KD, Derber LA, et al. Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. Arthritis Rheumatism. 2010;62(9):2633–2639. PubMed PMID: 20496417.
   PubMedGoogle Scholar
• Wang W, Li J. Predominance of IgG1 and IgG3 subclasses of autoantibodies to peptidylarginine deiminase 4 in rheumatoid arthritis. Clin Rheumatol. 2011 Apr;30(4):563–567. PubMed PMID: 21210288; eng.
   PubMed Web of Science ®Google Scholar
• Ishigami A, Uchida Y, Miyazaki T, et al. Two novel sandwich ELISAs identify PAD4 levels and PAD4 autoantibodies in patients with rheumatoid arthritis. Mod Rheumatol. 2013 Jul;23(4):794–803. PubMed PMID: 22986904; eng.
   PubMed Web of Science ®Google Scholar
• Ferucci ED, Darrah E, Smolik I, et al. Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations. J Rheumatol. 2013 Sep;40(9):1523–1528. PubMed PMID: 23908443; PubMed Central PMCID: PMCPMC3969032. eng.
   PubMed Web of Science ®Google Scholar
• Reyes-Castillo Z, Palafox-Sánchez CA, Parra-Rojas I, et al. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Clin Exp Immunol. 2015;182(2):119–131. PubMed PMID: 26149185.
   PubMed Web of Science ®Google Scholar
• Umeda N, Matsumoto I, Kawaguchi H, et al. Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases. Clin Rheumatol. 2016 May;35(5):1181–1188. PubMed PMID: 26415740; eng.
   PubMed Web of Science ®Google Scholar
• Navarro-Millán I, Darrah E, Westfall AO, et al. Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans. Arthritis Res Ther. 2016;18(1):241. PubMed PMID: 27770831.
   PubMedGoogle Scholar
• Martinez-Prat L, Lucia D, Ibarra C, et al. Antibodies targeting protein-arginine deiminase 4 (PAD4) demonstrate diagnostic value in rheumatoid arthritis. Ann Rheum Dis. 2019 Mar;78(3):434–436. PubMed PMID: 30297325; eng.
   PubMed Web of Science ®Google Scholar
• Cappelli LC, Konig MF, Gelber AC, et al. Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis. Arthritis Res Ther. 2018;20(1):59.
   PubMedGoogle Scholar
• Darrah E, Yu F, Cappelli LC, et al. Association of baseline peptidylarginine deiminase 4 autoantibodies with favorable response to treatment escalation in rheumatoid arthritis. Arthritis Rheumatol (Hoboken). 2018 Dec 3. PubMed PMID: 30507066; eng. DOI:10.1002/art.40791.
   Web of Science ®Google Scholar
• Guderud K, Mæhlen MT, Nordang GBN, et al. Lack of association among peptidyl arginine deiminase type 4 autoantibodies, PADI4 polymorphisms, and clinical characteristics in rheumatoid arthritis. J Rheumatol. 2018;45(9):1211–1219.
   PubMed Web of Science ®Google Scholar
• Pollmann S, Stensland M, Halvorsen EH, et al. Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate. Rheumatol Int. 2012;32(5):1271–1276. PubMed PMID: 21267570.
   PubMed Web of Science ®Google Scholar
• Ren J, Sun L, Zhao J. Meta-analysis: diagnostic accuracy of antibody against peptidylarginine deiminase 4 by ELISA for rheumatoid arthritis. Clin Rheumatol. 2017 Nov;36(11):2431–2438. PubMed PMID: 28887697; eng.
   PubMed Web of Science ®Google Scholar
• Mahler M. Population-based screening for ACPAs: a step in the pathway to the prevention of rheumatoid arthritis? Ann Rheum Dis. 2017 Nov;76(11):e42. PubMed PMID: 28274912; eng.
   PubMed Web of Science ®Google Scholar
• Arnoux F, Mariot C, Peen E, et al. Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types. Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):E10169–e10177. PubMed PMID: 29109281; PubMed Central PMCID: PMCPMC5703315. eng.
   PubMed Web of Science ®Google Scholar
• Elliott SE, Kongpachith S, Lingampalli N, et al. Affinity maturation drives epitope spreading and generation of proinflammatory anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheumatol (Hoboken). 2018 Dec;70(12):1946–1958. PubMed PMID: 29927104; PubMed Central PMCID: PMCPMC6261684. eng.
   PubMed Web of Science ®Google Scholar
• Gomez AKS, Lingampalli N, Cisar C, et al. Characterization of monoclonal anti-pad4 autoantibodies from rheumatoid arthritis patients: functional implications for citrullination and disease progression [abstract]. Arthritis Rheumatol. 2018;70(suppl):10.
   Google Scholar
• Koziel J, Mydel P, Potempa J. The link between periodontal disease and rheumatoid arthritis: an updated review. Curr Rheumatol Rep. 2014 Mar;16(3):408. PubMed PMID: 24458478; PubMed Central PMCID: PMCPMC3930831. eng.
   PubMed Web of Science ®Google Scholar
• Sakkas LI, Daoussis D, Liossis S-N, et al. The infectious basis of ACPA-positive rheumatoid arthritis [Mini review]. Front Microbiol. 2017;8(1853). English. DOI:10.3389/fmicb.2017.01853.
   PubMedGoogle Scholar
• Shimada A, Kobayashi T, Ito S, et al. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis. J Periodontal Res. 2016 Feb;51(1):103–111. PubMed PMID: 26094771; eng.
   PubMed Web of Science ®Google Scholar
• Kinloch A, Lundberg K, Wait R, et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum. 2008 Aug;58(8):2287–2295. PubMed PMID: 18668562; eng.
   PubMed Web of Science ®Google Scholar
• Spengler J, Lugonja B, Ytterberg AJ, et al. Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid. Arthritis Rheumatol (Hoboken). 2015;67(12):3135–3145. PubMed PMID: 26245941.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Chen B, Mittereder N, et al. Spontaneous Secretion of the Citrullination Enzyme PAD2 and Cell Surface Exposure of PAD4 by Neutrophils [Original Research]. Front Immunol. 2017;8(1200). English. DOI:10.3389/fimmu.2017.01200.
   Google Scholar
• Shi J, Darrah E, Sims GP, et al. Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis. Ann Rheum Dis. 2018;77(1):141–148. PubMed PMID: 29070531.
   PubMed Web of Science ®Google Scholar
• Darrah E, Martinez-Prat L, Mahler M. Clinical utility of antipeptidyl arginine deiminase type 4 antibodies. J Rheumatol. 2019;jrheum.180905. DOI:10.3899/jrheum.180905
   PubMed Web of Science ®Google Scholar
• Giles JT, Darrah E, Danoff S, et al. Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease. PloS One. 2014;9(6):e98794. PubMed PMID: 24901704; PubMed Central PMCID: PMCPMC4047055. eng.
   PubMed Web of Science ®Google Scholar
• Tilstra JS, Lienesch DW. Rheumatoid Nodules. Dermatol Clin. 2015 Jul;33(3):361–371. PubMed PMID: 26143419; eng.
   PubMed Web of Science ®Google Scholar
• Westhoff G, Listing J, Zink A. Loss of physical independence in rheumatoid arthritis: interview data from a representative sample of patients in rheumatologic care. Arthritis Care Res. 2000 Feb;13(1):11–22. PubMed PMID: 11094922; eng.
   PubMed Web of Science ®Google Scholar
• Kelly C, Iqbal K, Iman-Gutierrez L, et al. Lung involvement in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol. 2016 Oct;30(5):870–888. PubMed PMID: 27964793; eng.
   PubMed Web of Science ®Google Scholar
• Seaman A, Darrah E, Infantino M, et al. Anti-peptidyl-arginine deaminase 3 (PAD3) antibodies as a promising marker to measure joint damage in patients with rheumatoid arthritis. Autoimmun Rev. 2016 Jul;15(7):776–780. PubMed PMID: 26997641.
   PubMed Web of Science ®Google Scholar
• Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017 Jun 10;389(10086):2338–2348. PubMed PMID: 28612748; eng.
   PubMed Web of Science ®Google Scholar
• Ferro F, Elefante E, Luciano N, et al. One year in review 2017: novelties in the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2017;35(5):721–734. PubMed PMID: 28956527; eng.
   PubMed Web of Science ®Google Scholar
• Tjin CC, Wissner RF, Jamali H, et al. Synthesis and biological evaluation of an indazole-based selective protein arginine deiminase 4 (PAD4) inhibitor. ACS Med Chem Lett. 2018 Oct 11;9(10):1013–1018. PubMed PMID: 30344909; PubMed Central PMCID: PMCPMC6187405. eng.
   PubMed Web of Science ®Google Scholar
• Jamali H, Khan HA, Tjin CC, et al. Cellular Activity of New Small Molecule Protein Arginine Deiminase 3 (PAD3) Inhibitors. ACS Med Chem Lett. 2016 Sep 8;7(9):847–851. PubMed PMID: 27660689; PubMed Central PMCID: PMCPMC5018872. eng.
   PubMed Web of Science ®Google Scholar
• Reyes-Castillo Z, Munoz-Valle JF, Llamas-Covarrubias MA. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis. Autoimmun Rev. 2018 Feb;17(2):94–102. PubMed PMID: 29196243; eng.
   PubMed Web of Science ®Google Scholar